1.0CRIhttps://cri1149.fr/en/Julien Tourneur-Marsillehttps://cri1149.fr/en/author/julien_t/rich600338<blockquote class="wp-embedded-content" data-secret="3dXjlWbWvU"><a href="https://cri1149.fr/en/news/imap-platform-awarded-ibisa-label/">iMAP platform awarded IBiSA label</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cri1149.fr/en/news/imap-platform-awarded-ibisa-label/embed/#?secret=3dXjlWbWvU" width="600" height="338" title="“iMAP platform awarded IBiSA label” — CRI" data-secret="3dXjlWbWvU" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://cri1149.fr/wp-includes/js/wp-embed.min.js </script> https://cri1149.fr/wp-content/uploads/2026/02/IBISA.png16791125The iMAP platform – Multimodal Imaging Applied to Pathology is proud to announce that it has been awarded the IBiSA label for a period of two years. In early 2025, iMAP applied to join the IBiSA network, which supports technological platforms in their technological and methodological development projects, as well as in their quality management […]